Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

NCT05398094 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage III
KRAS P.G12C

Interventions

DRUG: Sotorasib

Sponsor

Fundación GECP